Find Lumateperone Tosylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1187020-80-9, Lumateperone (tosylate), Iti-007 tosylate, Iti 007, Lumateperone tosylate [usan], Jie88n006o
Molecular Formula
C31H36FN3O4S
Molecular Weight
565.7  g/mol
InChI Key
LHAPOGAFBLSJJQ-GUTACTQSSA-N
FDA UNII
JIE88N006O

Lumateperone Tosylate
1 2D Structure

Lumateperone Tosylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic acid
2.1.2 InChI
InChI=1S/C24H28FN3O.C7H8O3S/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17;1-6-2-4-7(5-3-6)11(8,9)10/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3;2-5H,1H3,(H,8,9,10)/t20-,21-;/m0./s1
2.1.3 InChI Key
LHAPOGAFBLSJJQ-GUTACTQSSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
2.1.5 Isomeric SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
2.2 Other Identifiers
2.2.1 UNII
JIE88N006O
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Iti-007

2. Iti-722

3. Lumateperone

2.3.2 Depositor-Supplied Synonyms

1. 1187020-80-9

2. Lumateperone (tosylate)

3. Iti-007 Tosylate

4. Iti 007

5. Lumateperone Tosylate [usan]

6. Jie88n006o

7. 1-(4-fluorophenyl)-4-[(10r,15s)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic Acid

8. Lumateperone Tosylate (usan)

9. Lumateperone(iti-007)

10. Caplyta

11. Chembl3233142

12. Unii-jie88n006o

13. Caplyta (tn)

14. Schembl1769664

15. Iti-007iti-007

16. Dtxsid701026210

17. Lumateperone Tosylate [who-dd]

18. Cs-5540

19. Ac-36919

20. Bl167386

21. Hy-19733

22. Lumateperone Tosylate [orange Book]

23. D11170

24. A858354

25. Q27281520

26. 1-(4-fluoro-phenyl)-4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one Tosylate Salt

27. 1-(4-fluorophenyl)-4-((6br,10as)-3-methyl-2,3,6b,7,10,10a-hexahydro-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(9h)-yl)butan-1-one 4-methylbenzenesulfonate

28. 1-(4-fluorophenyl)-4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalin-8(7h)-yl)butan-1-one 4-methylbenzenesulfonate (1:1)

29. 1-(4-fluorophenyl)-4-[(6br,10as)-2,3,6b,9,10,10a-hexahydro-3-methyl-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl]-1-butanone 4-methylbenzenesulfonate

30. 1-butanone, 1-(4-fluorophenyl)-4-((6br,10as)-2,3,6b,9,10,10a-hexahydro-3-methyl-1h-pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalin-8(7h)-yl)-, 4-methylbenzenesulfonate (1:1)

2.3.3 Other Synonyms

1. Iti-722

2. 313368-91-1

3. Lumateperone

4. 70bsq12069

2.4 Create Date
2009-11-02
3 Chemical and Physical Properties
Molecular Weight 565.7 g/mol
Molecular Formula C31H36FN3O4S
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass565.24105597 g/mol
Monoisotopic Mass565.24105597 g/mol
Topological Polar Surface Area89.5 Ų
Heavy Atom Count40
Formal Charge0
Complexity799
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

Interquim SA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Interquim

02

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

03

Suanfarma

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSuanfarma, at the Core of a Better Life.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Suanfarma

04

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Dr Reddy Company Banner

05

Medichem S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Medichem

06

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

07

Dasami Lab

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Dasami Lab

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Zydus Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Zydus Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Zhejiang Tianyu Pharmaceutical Co....

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Zhejiang Tianyu Pharmaceutical Co....

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622658600,"product":"LUMATEPERONE TOSYLATE (QTY: 81 GMS)","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"MUNICH","customer":"ATTN: MRS. OLIVIA MERKEL LMU MUNICH","customerCountry":"GERMANY","quantity":"0.08","actualQuantity":"81","unit":"GMS","unitRateFc":"180.2","totalValueFC":"14300.7","currency":"USD","unitRateINR":12984.654444444444,"date":"03-Jun-2021","totalValueINR":"1051757.01","totalValueInUsd":"14300.7","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"2195897","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637865000,"product":"LUMATEPERONE TOSYLATE","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"HAMBURG - FUHLSBUETT","customer":"LMU MUNICH, DEPARTMENT OF PHARMACY","customerCountry":"GERMANY","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"21841","totalValueFC":"2148.5","currency":"USD","unitRateINR":1600000,"date":"26-Nov-2021","totalValueINR":"160000","totalValueInUsd":"2148.5","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"6294148","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652121000,"product":"LUMATEPERONE TOSYLATE (QTY:20.5 GMS) (FO","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"YARA SHEHAD (SUPPLY CHAIN SPECIALIS","customerCountry":"EGYPT","quantity":"0.02","actualQuantity":"20.5","unit":"GMS","unitRateFc":"21.5","totalValueFC":"427","currency":"USD","unitRateINR":1609.7560975609756,"date":"10-May-2022","totalValueINR":"33000","totalValueInUsd":"427","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"1289777","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661193000,"product":"LUMATEPERONE TOSYLATE","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"ATCO PHARMA FOR PHARMACEUTICAL IND.","customerCountry":"EGYPT","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"41.7","totalValueFC":"1973.2","currency":"USD","unitRateINR":3140,"date":"23-Aug-2022","totalValueINR":"157000","totalValueInUsd":"1973.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3668229","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675621800,"product":"LUMATEPERONE TOSYLATE","address":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,","city":"ERRADADDA,TELANGANA","supplier":"DASAMI LAB PRIVATE ","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"BAGO GROUP","customerCountry":"ARGENTINA","quantity":"0.40","actualQuantity":"0.4","unit":"KGS","unitRateFc":"17000","totalValueFC":"6550.4","currency":"USD","unitRateINR":1352500,"date":"06-Feb-2023","totalValueINR":"541000","totalValueInUsd":"6550.4","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"7569293","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-166\/182, A BLOCK, NORTH WING,, 105-108, IST FLOOR CHALLA ESTATES,, ERRADADDA,TELANGANA","customerAddress":""}]
03-Jun-2021
06-Feb-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for relapse in adult patients with schizophrenia.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 05, 2024

blank

01

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for relapse in adult patients with schizophrenia.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

November 05, 2024

blank

Details:

Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for the treatment of major depressive disorder.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 18, 2024

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for the treatment of major depressive disorder.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 18, 2024

blank

Details:

The intend to use the net proceeds from this offering to fund commercialization activities of Caplyta (lumateperone), which is indicated for the treatment of schizophrenia.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: J.P. Morgan

Deal Size: $575.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering April 24, 2024

blank

03

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : The intend to use the net proceeds from this offering to fund commercialization activities of Caplyta (lumateperone), which is indicated for the treatment of schizophrenia.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Undisclosed

April 24, 2024

blank

Details:

Caplyta (lumateperone) proceeds will support continued commercialization in treating schizophrenia and bipolar depression.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: J.P. Morgan

Deal Size: $500.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering April 17, 2024

blank

04

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta (lumateperone) proceeds will support continued commercialization in treating schizophrenia and bipolar depression.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Undisclosed

April 17, 2024

blank

Details:

Caplyta (lumateperone) proceeds will support commercialization activities for its use in schizophrenia and bipolar depression treatment.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: J.P. Morgan

Deal Size: $500.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering April 16, 2024

blank

05

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta (lumateperone) proceeds will support commercialization activities for its use in schizophrenia and bipolar depression treatment.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Undisclosed

April 16, 2024

blank

Details:

Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for the treatment of major depressive disorder.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 16, 2024

blank

06

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta (lumateperone) is an oral, once daily atypical antipsychotic that acts as a 5-HT2A & D2 receptor antagonist. It is being evaluated for the treatment of major depressive disorder.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 16, 2024

blank

Details:

Lumateperone tosylate capsule has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is used for the treatment of Schizophrenia.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta-Generic

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 29, 2023

blank

07

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Lumateperone tosylate capsule has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is used for the treatment of Schizophrenia.

Brand Name : Caplyta-Generic

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 29, 2023

blank

Details:

Caplyta® (lumateperone) has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is investigated for the treatment of bipolar I or bipolar II disorder.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 31, 2023

blank

08

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta® (lumateperone) has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is investigated for the treatment of bipolar I or bipolar II disor...

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

May 31, 2023

blank

Details:

Caplyta® (lumateperone) has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is used for the treatment of major depressive disorers.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 28, 2023

blank

09

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Caplyta® (lumateperone) has a combination mechanism of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors. It is used for the treatment of major depressive disorers.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

March 28, 2023

blank

Details:

The results confirm the favorable effects of Caplyta (lumateperone) 42mg on body weight and morphology as demonstrated by minimal and similar to placebo mean changes from baseline in weight, BMI (kg/m2) and waist circumference in short-term studies.


Lead Product(s): Lumateperone Tosylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Caplyta

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 08, 2022

blank

10

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : The results confirm the favorable effects of Caplyta (lumateperone) 42mg on body weight and morphology as demonstrated by minimal and similar to placebo mean changes from baseline in weight, BMI (kg/m2) and waist circumference in short-term studies.

Brand Name : Caplyta

Molecule Type : Small molecule

Upfront Cash : Not Applicable

December 08, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

read-more
read-more

01

Bakul Group

India
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Bakul Group

India
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

CAS Number : 96-30-0

End Use API : Lumateperone Tosylate

About The Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (AP...

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

CAS Number : CAS-3874-54-2

End Use API : Lumateperone Tosylate

About The Company : Hebi Xinhe Pharmaceutical Co., Ltd. is a subsidiary of Tianjin Zhennuo Pharmaceutical Group Co., Ltd., with a registered capital of CNY 100 million. Located in ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 10464938

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-12

blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 11052084

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209500

Patent Use Code : U-3363

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-30

blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 12122792

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209500

Patent Use Code : U-4019

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-12-10

blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 11753419

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-12-10

blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : RE48825

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-02-12

blank

06

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 10960009

Drug Substance Claim :

Drug Product Claim :

Application Number : 209500

Patent Use Code : U-814

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2034-12-03

blank

07

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : RE48839

Drug Substance Claim :

Drug Product Claim :

Application Number : 209500

Patent Use Code : U-814

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2033-08-19

blank

08

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 9956227

Drug Substance Claim :

Drug Product Claim :

Application Number : 209500

Patent Use Code : U-2714

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-12-03

blank

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 9199995

Drug Substance Claim :

Drug Product Claim :

Application Number : 209500

Patent Use Code : U-2713

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-12

blank

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LUMATEPERONE TOSYLATE

US Patent Number : 11806348

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209500

Patent Use Code : U-3363

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-30

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Lumateperone Manufacturers

A Lumateperone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lumateperone, including repackagers and relabelers. The FDA regulates Lumateperone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lumateperone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Lumateperone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Lumateperone Suppliers

A Lumateperone supplier is an individual or a company that provides Lumateperone active pharmaceutical ingredient (API) or Lumateperone finished formulations upon request. The Lumateperone suppliers may include Lumateperone API manufacturers, exporters, distributors and traders.

click here to find a list of Lumateperone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Lumateperone USDMF

A Lumateperone DMF (Drug Master File) is a document detailing the whole manufacturing process of Lumateperone active pharmaceutical ingredient (API) in detail. Different forms of Lumateperone DMFs exist exist since differing nations have different regulations, such as Lumateperone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Lumateperone DMF submitted to regulatory agencies in the US is known as a USDMF. Lumateperone USDMF includes data on Lumateperone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lumateperone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Lumateperone suppliers with USDMF on PharmaCompass.

Lumateperone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lumateperone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Lumateperone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Lumateperone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Lumateperone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lumateperone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Lumateperone suppliers with NDC on PharmaCompass.

Lumateperone GMP

Lumateperone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Lumateperone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lumateperone GMP manufacturer or Lumateperone GMP API supplier for your needs.

Lumateperone CoA

A Lumateperone CoA (Certificate of Analysis) is a formal document that attests to Lumateperone's compliance with Lumateperone specifications and serves as a tool for batch-level quality control.

Lumateperone CoA mostly includes findings from lab analyses of a specific batch. For each Lumateperone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Lumateperone may be tested according to a variety of international standards, such as European Pharmacopoeia (Lumateperone EP), Lumateperone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lumateperone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty